See also this year's filing and all EDGAR filings for this company.
PDF Report 0001061027_2021_Viracta_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001061027, Viracta Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 22,144,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 1,103,000 |
| 4 | LiabilitiesCurrent | 3,310,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,164,667 |
| 9 | ResearchAndDevelopmentExpense | 11,182,218 |
| 10 | remainder_Expenses | 265,803 |
| 11 | remainder_Revenues | 513,924 |
| 12 | remainder_NetIncome | 811,496 |
| 13 | remainder_ComprehensiveNetIncome | -536 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 23,247,000 |
| 1 | Liabilities | 3,310,000 |
| 2 | Expenses | 21,612,688 |
| 3 | Revenues | 513,924 |
| 4 | StockholdersEquity | 19,937,000 |
| 5 | NetIncome | -20,287,268 |
| 6 | ComprehensiveNetIncome | -20,287,536 |
| 7 | BaseVar | 24,747,822 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.75 |
| 9 | EconomicCapitalRatio | 2.85 |